In contrast, chronic SH-4-54 treatment of representative ERα-positive cells that initially respond to STAT5 signals results in STAT3 activation and up-regulation of xCT, potentially leading to a more aggressive cancer subtype. The gene discussed is SLC7A11; the disease is cancer.